SYROS PHARMACEUTICALS
Syros Pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. Syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical R&D. Central to the Syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of Syros' senior leadership. While this scientific approach has applications in many therapeutic areas, Syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs.
SYROS PHARMACEUTICALS
Industry:
Biotechnology Genetics Life Science Pharmaceutical
Founded:
2012-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.syros.com
Total Employee:
101+
Status:
Active
Contact:
(617) 744-1340
Email Addresses:
[email protected]
Total Funding:
620.47 M USD
Technology used in webpage:
Domain Not Resolving HSTS Mobile Non Scaleable Content Sitelinks Search Box CrUX Top 50m DNSSEC ASP.NET Microsoft OpenResty Sectigo SSL
Similar Organizations
23andMe
23andMe is a DNA testing technology company that enables its users to access their ancestry, genealogy, and inherited traits.
Alvotech
Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Avidity Biosciences
Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies for its patients.
Element Biosciences
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.
Eyenovia
Eyenovia is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.
Standard BioTools
Standard BioTools is a biotech tools company that creates microfluidic-based chips and instrumentation for biological research.
Lifebit
Lifebit CloudOS is the intelligent genomics platform that is the industry standard for unified, secure research over distributed big data.
Synthego
Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.
Verve Therapeutics
Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-07-07 | TYME | TYME acquired by Syros Pharmaceuticals | 60 M USD |
| 2020-12-07 | Orsenix | Orsenix acquired by Syros Pharmaceuticals | 12 M USD |
Investors List
Deep Track Capital
Deep Track Capital investment in Post-IPO Equity - Syros Pharmaceuticals
Flagship Pioneering
Flagship Pioneering investment in Post-IPO Equity - Syros Pharmaceuticals
Adage Capital Management
Adage Capital Management investment in Post-IPO Equity - Syros Pharmaceuticals
Samsara BioCapital
Samsara BioCapital investment in Post-IPO Equity - Syros Pharmaceuticals
Blue Owl
Blue Owl investment in Post-IPO Equity - Syros Pharmaceuticals
Invus
Invus investment in Post-IPO Equity - Syros Pharmaceuticals
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Post-IPO Equity - Syros Pharmaceuticals
Dafna Capital Management
Dafna Capital Management investment in Post-IPO Equity - Syros Pharmaceuticals
Ally Bridge Group
Ally Bridge Group investment in Post-IPO Equity - Syros Pharmaceuticals
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Post-IPO Equity - Syros Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2023-10-02 | After 2 partners walk away, Syros cuts 35% of workforce and lines up new CEO |
Official Site Inspections
http://www.syros.com Semrush global rank: 9.45 M Semrush visits lastest month: 379
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Syros Pharmaceuticals"
Board of Directors :: Syros Pharmaceuticals, Inc. (SYRS)
Fanucci serves on the boards of directors of several biotech companies, including Alnylam Pharmaceuticals, FORMA Therapeutics, Ironwood Pharmaceuticals and Momenta โฆSee details»
Leadership :: Syros Pharmaceuticals, Inc. (SYRS)
Gerald brings more than 20 years of senior leadership and legal experience in the biotechnology industry. Before joining Syros, he was Executive Vice President of Business Operations and General Counsel at Tokai Pharmaceuticals, where โฆSee details»
Syros Announces Planned CEO Leadership Transition and Strategic ...
Oct 2, 2023 Syros is streamlining its organization and implementing an approximately 35% workforce reduction to reflect its focus on the clinical development of tamibarotene and โฆSee details»
Profile :: Syros Pharmaceuticals, Inc. (SYRS)
Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Company Info. Address: 35 CambridgePark Drive 4th Floor โฆSee details»
Company Information :: Syros Pharmaceuticals, Inc. (SYRS)
Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. View Profile View Management Team. Contact Information. โฆSee details»
Syros Pharmaceuticals - Crunchbase Company Profile & Funding
Syros Pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. Syros has โฆSee details»
Syros Pharmaceuticals - LinkedIn
Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that ...See details»
About Us :: Syros Pharmaceuticals, Inc. (SYRS)
The genes expressed - turned on, off, up or down - in any given cell determine its type and function. When genes are expressed at the wrong time or in the wrong amounts, it can lead to โฆSee details»
Syros Pharmaceuticals, Inc. (SYRS) - Yahoo Finance
Find the latest Syros Pharmaceuticals, Inc. (SYRS) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Investor Relations :: Syros Pharmaceuticals, Inc. (SYRS)
Nov 12, 2024 Syros Pharmaceuticals, Inc. Symbol Nasdaq: SYRS. Price. Change. Volume. 52 week Low/High. Day Low/High. Company Overview. Syros is committed to developing new โฆSee details»
Syros Announces Planned CEO Leadership Transition and ... - Nasdaq
Oct 2, 2023 Syros Pharmaceuticals, a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced a โฆSee details»
SYRS.O - | Stock Price & Latest News | Reuters
2 days ago Get Syros Pharmaceuticals Inc (SYRS.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsSee details»
Syros Pharmaceuticals (SYRS) Earnings Date and Reports 2024
6 days ago Syros Pharmaceuticals issued Q3 2024 earnings on October 31, 2024, reporting an EPS of -$0.68, which beat analysts' consensus estimates of -$0.76 by $0.08. With a trailing โฆSee details»
Syros - Wikipedia
Syros (Greek: ฮฃฯฯฮฟฯ), also known as Siros or Syra, is a Greek island in the Cyclades, in the Aegean Sea.It is 78 nautical miles (144 km) south-east of Athens.The area of the island is โฆSee details»
Our Commitment to Diversity, Equity & Inclusion :: Syros ...
Syros is dedicated to furthering diversity, equity, and inclusion (DEI) within our company, in our industry, as well as beyond, and we are fully aligned to the DEI principles outlined in โฆSee details»
Syros Tourist Lodgements Association - Visit Syros
The Syros Tourist Lodgements Association would like to welcome you to its official website and invite you, through this first-time visit, to explore the majestic and fabulous island of Syros. Get โฆSee details»
Syros Reports Fourth Quarter and Full Year 2021 Financial Results โฆ
Mar 15, 2022 Syros is advancing a robust clinical-stage pipeline, including: tamibarotene, a first-in-class oral selective RARฮฑ agonist in RARA-positive patients with higher-risk โฆSee details»
Our People :: Syros Pharmaceuticals, Inc. (SYRS)
Working at Syros is an incredibly rewarding experience. I work on challenging and stimulating projects while receiving guidance and support from colleagues who are always willing to share โฆSee details»
14 Things To Do In Syros Island That Will Make You Fall In Love โฆ
Feb 15, 2023 How long should you stay in Syros? If youโre short on time or just want a quick taste of the island, 1-2 days can be enough to explore the main highlights of Ermoupolis, the โฆSee details»